Mersana Therapeutics Inc (MRSN) earnings · rev $40.5M
These earnings events as JSON? API free 100/dayMersana Therapeutics Inc (MRSN) is a biotechnology company listed on NASDAQ.
This MRSN earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported MRSN revenue for 2024-12-31 was $40.5M. Net income was -$69.2M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. MRSN currently screens at market cap $145.4M.
When the next MRSN 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 9.9% from 2023-12-31 to 2024-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full MRSN research stays on the stock page; the tape stays on the quote page.
MRSN earnings FAQ
What are MRSN's latest revenue and net income?
Latest cached Mersana Therapeutics Inc (MRSN) revenue for Dec 31, 2024 was $40.5M. Net income was -$69.2M. Statements: https://lician.com/financials/mrsn
What is MRSN's latest diluted EPS?
Latest cached Mersana Therapeutics Inc (MRSN) diluted EPS for Dec 31, 2024 was -$0.56.
What period does the latest MRSN earnings print cover?
The latest cached Mersana Therapeutics Inc (MRSN) earnings print covers Dec 31, 2024. The prior cached period on this page is Dec 31, 2023.
How did MRSN revenue change from the prior cached period?
Cached Mersana Therapeutics Inc (MRSN) revenue was up 9.9% from $36.9M (Dec 31, 2023) to $40.5M (Dec 31, 2024). Statements: https://lician.com/financials/mrsn
Where are MRSN earnings listed?
Cached earnings facts for Mersana Therapeutics Inc (MRSN) are listed at https://lician.com/earnings/mrsn. Statements: https://lician.com/financials/mrsn
Not investment advice.